AB
Auxilium Biotechnologies Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$3.9Msold at filing
Total offering$10M$6.1M still open
Investors in the raise16count reported to the SEC
FiledDec 11, 2025first sale Sep 18, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Yacov KofflerExecutive Officer, Director
Craig AndrewsDirector
Mark TuszynskiDirector
Robert EnglerDirector
Executive officers, directors and promoters as listed on the Form D.